Topical Drug Bioavailability, Bioequivalence, and Penetration /

Topical Drug Bioavailability, Bioequivalence, and Penetration /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Shah, Vinod P. (Editor ), Maibach, Howard I. (Editor ), Jenner, John. (Editor )
Formato: eBook
Lenguaje:English
Publicado: New York, NY : Springer New York : Imprint: Springer, 2014.
Edición:2nd ed. 2014.
Materias:
Pharmacology.
Animal physiology.
Biophysics.
Biological physics.
Pharmacology/Toxicology.
Animal Physiology.
Biological and Medical Physics, Biophysics.
Tabla de Contenidos:
  • 1 Percutaneous Absorption
  • 2 Animal Models for Percutaneous Absorption
  • 3 Mitigating Dermal Exposure to Agrochemicals
  • 4 Importance of In Vitro Drug Release
  • 5 Diffusion Cell Design
  • 6 In Vitro Product Quality Tests and Product Performance Tests for Topical and Transdermal Drug Products
  • 7 Safety and efficacy testing of topical products; Practical considerations
  • 8 Challenges in Evaluating Bioequivalence of Topical Dermatological Drug Products
  • 9 Methods for the Assessment of Bioequivalence of Topical Dosage Forms: Correlations, Optimization Strategies and Innovative Approaches
  • 10 Application of Microdialysis in Assessing Cutaneous Bioavailability
  • 11 Follicular Drug Penetration
  • 12 Development of Pilosebaceous Unit-Targeted Drug Products
  • 13 Deep Percutaneous Penetration into Muscles and Joints: Update
  • 14 Efficacy & Toxicity of Microneedle based devices
  • 15 Mathematical Models for Topical and Transdermal Drug Products
  • 16 Transdermal Patches: An Industrial Perspective on the Relevance of in vitro Skin Permeation Studies and Approaches on Design of Manufacturing Processes
  • 17 Transdermal Drug Delivery Systems.  Regulatory Considerations:  NDA and ANDA Requirements
  • 18 Transdermal Estradiol and Testosterone Transfer in Man: Existence, Models, and Strategies for Prevention
  • 19 Effects of occlusion on dermal drug delivery: implications for bioequivalence measurement
  • 20 Challenges with Clinical Endpoints - Bioequivalence
  • 21 Clinical Considerations of Bioequivalence For Topical Dermatologic Drugs
  • 22 OECD Test Guideline 428 - A method for in vitro percutaneous absorption measurement?
  • 23 Bioequivalence, Quality, and Novel Assessment Technologies for Topical Products: Current Challenges and Future Prospects.

Ejemplares similares